Trial intelligence / Profile preview

Topical creams for vitiligo induction

NCT01082393Phase 4Completed

Sponsor
Ghent University Hospital
Start
Feb 2010
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Tacrolimus Ointment 0.1% Iwaki, Pimecrolimus vehicle + topical corticosteroid, mometasone furoate nasal spray in Vitiligo, sponsored by Ghent University Hospital. Started Feb 2010; status: completed.

02

Drugs

Tacrolimus Ointment 0.1% IwakiPimecrolimus vehicle + topical corticosteroidmometasone furoate nasal spray
03

Conditions

Vitiligo

Beyond the preview

Go deeper on NCT01082393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01082393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call